NEOIMMUNE
Universal Medicine is a technology developer in the field of immune system, dedicated to the development of key technologies for high-throughput reading and writing of T and B lymphocyte receptor profiles and their applications in clinical testing and treatment, focusing on technology developers in the field of immune system . Recently announced the completion of a 30 million RMB Pre-A round of strategic financing. WinX Capital is acting as a financial advisor. This round of investment was initi... ated by Kangsheng Global. Ruijiang Kangsheng Fund managed by Ruijiang Investment led the investment. The investors included Spark Venture Capital and Yangtze River Source Fund. This round of funds will be mainly used for the promotion of hematological tumor MRD products and the research and development of new clinical products.
NEOIMMUNE
Industry:
Biotechnology Health Care Medical
Founded:
2019-12-01
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.neoimmune.cn
Total Employee:
11+
Status:
Active
Contact:
+86 0755-32960061
Email Addresses:
[email protected]
Total Funding:
30 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro Pound Sterling Japanese Yen
Current Employees Featured
Investors List
Spark Ventures
Spark Ventures investment in Seed Round - NeoImmune
Kindstar Global (Beijing) Medicine Technology
Kindstar Global (Beijing) Medicine Technology investment in Seed Round - NeoImmune
